chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient noted tenderness from right lower neck extending down to right elbow, erythema to right arm. She went to an urgent care clinic to seek care, and was given information about home care and recommendations for ibuprofen and topical hydrocortisone if needed.
Patient complaining of muscle aches, fever, and fatigue two weeks after getting the Shingrix immunization. I offered to call the patient's physician. She declined and refuse to provide her MD information. I told her I will contact the manufacture.
Light headed  and dizziness, left side headache  tingling sensation down entire left arm to finger tips, and up to chin   neck and chest area for about  20 minutes
Unstable Blood pressure beginning on February 16, 2021 - Feb 16 2021 ? blood pressure 165/75, dropped within 45 minutes 94/66; Ran high but not too high through February. - April 17, 2021 ? 178/88, dropped to April 18, 100/75 - May 29, 2021 ? 97/63, 86/58, 92/63, until finally came to 120/63 - Nov 12, 2021 ? 148/76, down to 94/66, heart rate at 105 - Nov 13, 2021 ? 154/77 with HR 106, dropped to 127/74, 102,  - Major one ? Nov 15, 2021 - 157/65, dropped to 84/58, dropped to 78/58, shot back up 189/52, 122/41, 85/61, 82/46, 71/46, 84/55. HR was 110-42.  - Nov 16: high low high low, low, low, low, finally climbed back up 120/76 to a regular blood pressure and we?ve been adjusting my medication and I continue to be low.
Fever, nausea, swelling (hives around site). This lasted for 5 days.  Should have done something about it; just "toughed it out" with cold medicine.
25JAN96 pt had fever,sore arm,rash during the noc had noc sweats;rash over upper body intense muscle soreness & fever 102;advised to see PP-MD called & confirmed rxn to vax;
Client c/o sharp pain to the lower back (L side) and voice that pain occurred immediately following vaccine administration.   Client voice that she has no prior medical history.  Client seen by EMT and cleared to go home.  Client advised to contact pcp if symptom worsens or if an other reaction arises.
Information has been received from a dentist (D.M.D.) concerning a 3 year old male patient, a twin, who was autistic and whose mother was vaccinated with Rhogham during pregnancy. On an unspecified date, the patient was vaccinated with a dose of MMR (lot # unknown). The doctor reported that the patient was diagnosed autistic at birth. However, following MMR vaccination things became worse. Unspecified medical attention was sought. Diagnostic studies were performed and results were high level mercury count. It was noted that the patient had more developmental delays than his twin. It was also reported that the patient was involved in a study (not specific). The doctor reported Rhogham used to have mercury in it. Upon internal review, autistic was determined to be an other important medical event (OMIC). Additional information has been requested. The dentist reported the patient's twin brother had a similar experience following vaccination with MMR.
Within 15minutes after receiving vaccine, patient reported mild dizziness & feeling of warmth.  BP110/78.  Requested & provided water. Felt better after several minutes & stated  symptoms resolved.  Sat onsite with spouse until 9:30am, then exited site ambulatory, accompanied by spouse.
Patient developed a red, itchy, warm welt at the site of injection. Patient called MD who advised patient to use cold compresses and acetaminophen.
swelling and redness at the injection  site (left deltoid); redness; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE SWELLING (swelling and redness at the injection  site (left deltoid)) and VACCINATION SITE ERYTHEMA (redness) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced VACCINATION SITE SWELLING (swelling and redness at the injection  site (left deltoid)) and VACCINATION SITE ERYTHEMA (redness). At the time of the report, VACCINATION SITE SWELLING (swelling and redness at the injection  site (left deltoid)) and VACCINATION SITE ERYTHEMA (redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment Medications were not provided by the reporter.
Noticed visibly distended lymph nodes in right side of his neck.  A little bigger than a pea.
The patient stated that she gets paralyzed after getting vaccines.  I asked her if she had someone in the pharmacy to help her. She said she came alone.  I told her I would have her wait 30mins after dose to make sure there were no issues. After I gave her the shot, she looked at me and said that didn't hurt at all. Then she looked and said my neck hurts. So I had her take deep breaths with me to get her to calm down as she appeared anxious. She was doing great then she went limp. I held her head up and asked her is she was ok.   She said she was, but then her breathing become shallow. She was un responsive at this time with her tongue pushing her mask off her mouth.  So I lowered her mask and her tongue appeared to be enlarged.  I had my technician call 911 and I gave her a dose of epinephrine 0.3 mg.   She was unresponsive, but breathing on her own.  The paramedics came and got her vitals, placed her on stretcher, and put in a medicine line to give her medications if need be.  She left somewhat unresponsive. They said she should be fine  and took her to ER.
Neurological symptoms, specifically I have begun moving my mouth when I think (muttering) and I am unaware I am doing it and unable to control it. Onset was sudden and I have never experienced this before.
The vaccine given was expired past the 30-day recommendation. At this time there have been no s/s of an adverse event
two booster doses were administered to two patients after the published expiration date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (two booster doses were administered to two patients after the published expiration date) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (two booster doses were administered to two patients after the published expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (two booster doses were administered to two patients after the published expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment medication reported.   On 28 Mar 2022 vial was initially stored in refrigerator.
Patient went to restroom and was found by nurse sitting on commode with reports of "dizziness" and feeling "woozy." Pt. brought to first aid area for monitoring. V/S: Temp 94.8, HR 64, BP 183/81. Patient reported no SOB, itching, difficulty swallowing, or rash. Pt. remained alert and oriented x4.  V/S recheck at 1147: HR 66, BP 105/98. Pt. denied continued feeling of dizziness or feeling "woozy." Pt. released to care of daughter at 1221.
Information has been received from a registered nurse concerning a 49 year old female with no medical history or allergies who on 06-JUL-2010 was vaccinated SQ with the first 0.5 ml dose of VARIVAX (Merck) (lot # 665642/1457Y). Concomitant therapy included PETADOLEX, MIGRANAL, MIGRE-LIEF and alendronate sodium. On 10-JUL-2010 the patient experienced generalized rash, headache, stiffness of neck, slight fever, but no cough. The rash was on the face, torso, arms and back that was generalized eruption compatible with varicella with some vesicles and some without vesicles. There was lesion on the soft palate in the mouth (flat red lesion). The patient had a full case of chickenpox. There were no laboratory studies performed. The patient had an office visit to seek medical attention. At the time of report, the patient was recovering. Nurse also mentioned that the patient's husband had shingles but her husband was recovered prior to the patient getting VARIVAX (Merck). In follow-up, the nurse indicated that the VARIVAX (Merck) was administered into the left arm. On 10-JUL-2010 the patient contacted the doctor complaining of generalized rash and lesions, some with papules, some flat on face, neck, torso, and soft palate. The patient also complained of headache, mild stiff neck and low fever. On an unspecified date in 2010 the patient recovered from the events. Additional information is not expected.
itchiness around the injection site; redness around the injection site; puffiness/raised on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchiness around the injection site), VACCINATION SITE ERYTHEMA (redness around the injection site) and VACCINATION SITE SWELLING (puffiness/raised on the injection site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included PAROXETINE, VITAMIN C [ASCORBIC ACID] and ELDERBERRY [SAMBUCUS NIGRA] for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness around the injection site), VACCINATION SITE ERYTHEMA (redness around the injection site) and VACCINATION SITE SWELLING (puffiness/raised on the injection site). On 15-Jan-2021, VACCINATION SITE SWELLING (puffiness/raised on the injection site) had resolved. At the time of the report, VACCINATION SITE PRURITUS (itchiness around the injection site) and VACCINATION SITE ERYTHEMA (redness around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Slight headache; Delusional; A massive migraine; She felt like she was dying/falling from the fever; 103.8 fever; This spontaneous case was reported by a consumer and describes the occurrence of DELUSION (Delusional), MIGRAINE (A massive migraine), MALAISE (She felt like she was dying/falling from the fever), PYREXIA (103.8 fever) and HEADACHE (Slight headache) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.    On 07-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced DELUSION (Delusional), MIGRAINE (A massive migraine), MALAISE (She felt like she was dying/falling from the fever) and PYREXIA (103.8 fever). On 11-Feb-2021, the patient experienced HEADACHE (Slight headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of unknown. On 08-Feb-2021, PYREXIA (103.8 fever) had resolved. On 10-Feb-2021, MIGRAINE (A massive migraine) had resolved. At the time of the report, DELUSION (Delusional) and MALAISE (She felt like she was dying/falling from the fever) was resolving and HEADACHE (Slight headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Feb-2021, Body temperature: 103.8 f (High) 103.8 fever and within 30 minutes fever was 105 It became 101.8 with Tylenol and was 103 at night..         This case was linked to MOD-2021-029575 (Patient Link).; Sender's Comments:  MOD-2021-029575:same reporter , different patient.
even having had the shingles shot, you can get shingles/it happened to me!/suspect vaccination failure; get shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included COVID-19 VACCINE for prophylaxis.   Concurrent medical conditions included immunocompromised (compromised immune system).   On an unknown date, the patient received Shingles vaccine and COVID-19 VACCINE. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient received Shingles vaccine and Covid vaccine and had shingles. The patient stated that if you had a compromised immune system, even had the shingles shot, you could get shingles with the covid shot and no one wanted to talk about this, but it was happening, he/she know because it happened to him/her. The patient considered that there was a direct link to getting shingles and the covid vaccine. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
Swelling of L Arm. Headache, Neck Pain, Body Aches, Fever, Eye-twiching, neck soreness & swelling of lower extremities. Pt reporting S&S are becoming progressively worse. PCM aware and assessed pt on this date (06July2011). Per pt report, PCM will monitor and instructed to report to urgent care if S&S become worse. VSS within range this AM.
Patient came in for a well child visit and was given a expired vaccine. MOC was contacted after the appointment with no answer and no option to leave a voicemail. MOC will be contacted again to inform her and let her know that the vaccine given was expired and will need to have the vaccine given again in the future. Provider states the vaccine may likely still be effective but will need to be given again.
Client c/o dizziness.  (No sign of reaction noted to site.)  Client seen and assessed by EMT.  Vitals BP 173/76, HR 67, O2 99.  After 21 minutes of observation, client verbalized that she no longer felt symptoms and was cleared to go home by EMT.
Information has been received from a certified medical assistant (CMA) referring to an unknown number of patients of unknown age and gender. No relevant medical history or concurrent conditions were reported. The reporting medical assistant reported that, since 02-JUL-2015, these patients were vaccinated with doses of ROTATEQ (lot # K023537, expiration date 22-JUN-2016, oral; dose not reported) which were exposed to temperatures outside of the recommended range on 02-JUL-2015. No adverse experience was reported. This is one of several reports received from the same reporter. Additional information has been requested.
patient received a dose of pneumovax 23 under 65 y. o. in AUG 2018 and recently received the prevenar 13 at (65 y.o.); This spontaneous report was received from a pharmacist via Pfizer refers to a patient of currently 65 years of age. The patient's medical history, concurrent conditions and concomitant medications were not provided. On an unknown date in August 2018, when the patient was under 65 years of age, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) (dose, strength, route of administration, lot number and expiration date not reported) for prophylaxis. On an unknown date, approximately in April 2019, when the patient was at 65 years of age, the patient was vaccinated with pneumococcal 13v conj vaccine (crm197) (PREVNAR 13). It was reported that the time gap of at least 1 year was not maintained to administer pneumococcal 13v conj vaccine (crm197) (PREVNAR 13) (inappropriate schedule of vaccine administered).
Day after slight fever and sore throat. 3rd day, full on cold- stuffed up nose and sore throat
Pt presents with acute respiratory failure, 3L oxygen used. Covid treated with remdesivir, pt discharged.
AS OF MAY 24TH ALLERGIC REACTION TO A TETANUS SHOT, REDNESS, SWELLING 2CM. REDNESS SLOWLY MOVING UP LEFT ARM. PUSS OOZING FROM INJECTION SITE. AS OF MAY 27TH REDNESS AND SWELLING AT 4CM. LOOKS TO BE STILL SWELLING AND MOVING TOWARDS THE INSIDE OF THE ARM.
Patient was sitting in observation. C/O itchiness to throat and neck. No redness or hives noted. States she is probably having a panic attack. No redness or hives noted.  @2000 States itchiness to throat and neck has resolved. No complaints.
idiopathic cervical lymphadenopathy, urticaria & raised rash to deltoid of injection site that flares up randomly frequently, discoloration and skin texture change at injection site
This case was reported by a pharmacist via call center representative and described the occurrence of adverse reaction in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown. It was unknown if the reporter considered the adverse reaction to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The healthcare professional reported that the patient had a reaction to the SHINGRIX vaccine. The healthcare professional did not say what the reaction was, but it was bad enough that the patient waited a week to get the flu shot. No patient or vaccine information was given.
Received two (2) Varicella vaccines exactly 4 weeks apart, as instructed.  Developed severe itchy warm welt at injection site, along with migraine, photosensitivity, nausea, chills, hives and off/on low grade fever over the next few hours.  Next morning woke up to a huge, hot red itchy raised welt w/wide white ring around it and welt continued to travel all the way down my arm to my elbow over the next 2 weeks.  Went to clinic about 2-3 days after injection to show nurse.  She said to give it a few more days then call my Dr. I did and was told same to give it more time, they would see it at my checkup.  Don't remember the day I went to Dr. All in all, welt took 3-4 weeks to fully disappear, just in time for 2nd required injection. Red welt this time didn't last more than 2 weeks; however, over next 6 months suffered on/off lethargy, rapid greying and hair loss, headaches, unexplained irritability and foggy memory. I never saw such a strong reaction at injection site with white ring around it before.  I thought it was ringworm, but that didn't make sense!  Was told with no warning I had to have Chicken Pox vaccine for fertility cycle to move forward.  I wish I knew my rights then.
Chills, 101 degree fever, fatigue, aches for 24 hours  Extreme diarrhea with total purge of stomach for 24 hours   Less severe loose stool or diarrhea for 6 additional days Mild to severe fatigue when playing pickleball for 3 weeks Impaired depth perception when playing pickleball for 3 weeks Impaired hand-eye coordination when playing pickleball for 3 weeks  Moderate to severe brain fog for 3 weeks Moderate to severe flare ups of neck and upper back pain for 5 weeks
Meningococcal B vaccine inadvertently administered to age younger than 16 in a healthy child
Arm and face swelling, fever, bloodshot eyes, rapid heart rate, body pain, nausea, and headache. Took Tylenol, fluids, Benadryl, and rest.
Patient experienced flushing and hives for 90 minutes beginning 1 hour post-immunization.
Patient received his initial dose of Moderna Covid-19 vaccine on 7/23/2021 at 12:42 pm. He called pharmacy on 7/26/2021 to report the following. On Friday, 7/23/2021,after getting  Moderna vaccine he started experiencing side effects such as dizziness, nausea and vomiting. He is concerned that the side effects are not going away .The patient vomited 15 times on 7/26/2021.He can't keep down any medication or food . He does not have fever, headache ,but his blood pressure is low. I advised patient to stay hydrated and call his provider as he had post-vaccination symptoms for more than three days onset. P-t  came to pharmacy to pick up his medications next day, on 7/27/2021, and said he was going to see his doctor today and he started vomiting  blood.
Parent reported baseball size area of swelling @ inject site, accompanied by rash on arm; parent reported MD stated react to vax & put pt on ?Cortizone;
Administered doses that had expired; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 48-year-old male patient who received HAV (Havrix) (batch number 3F349, expiry date 9th August 2022) for prophylaxis.   On 3rd November 2022, the patient received Havrix. On 3rd November 2022, unknown after receiving Havrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 07-NOV-2022 Reporter's Comment: The reporter was a clinic manager. The reporter reported that the patient received Havrix vaccine which was expired on 09th August 2022. The vaccine administration facility was the same as the primary reporter. The reporter consented to follow up. Additional supportive information: The patient received a Havrix which was already expired, which led to expired vaccine used. This case was 1 of 6 cases for the patient reported by same reporter.; Sender's Comments:  US-GSK-US2022162505:Same reporter US-GSK-US2022162503:Same reporter US-GSK-US2022162506:Same reporter US-GSK-US2022162508:Same reporter US-GSK-US2022162509:Same reporter
next am felt feverish-worked part of day; 10NOV 2nd Hep B vax; 12NOV BP up, fainted, didn't feel well, flu-type discharged; no reaction from 1st vax;
Medical error- 1 year old was given MMRV + separate Varicella (dose 1 of 2). 10 days after vaccine, rash of small red dots on torso and back began. Child was taken to the clinic for check. On 11th day after vaccine, rash has extended to neck and face.